OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In‐silico Computational Investigations of AntiViral Lignan Derivatives as Potent Inhibitors of SARS CoV‐2
Dipen K. Sureja, Ashish Shah, Normi D. Gajjar, et al.
ChemistrySelect (2022) Vol. 7, Iss. 28
Open Access | Times Cited: 15
Dipen K. Sureja, Ashish Shah, Normi D. Gajjar, et al.
ChemistrySelect (2022) Vol. 7, Iss. 28
Open Access | Times Cited: 15
Showing 15 citing articles:
Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets
Zhouman He, Jia Yuan, Yuan‐wen Zhang, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1186-1210
Open Access | Times Cited: 9
Zhouman He, Jia Yuan, Yuan‐wen Zhang, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1186-1210
Open Access | Times Cited: 9
Potential JAK2 Inhibitors from Selected Natural Compounds: A Promising Approach for Complementary Therapy in Cancer Patients
Samaneh Vaziri–Amjad, Reza Rahgosha, Amir Taherkhani
Evidence-based Complementary and Alternative Medicine (2024) Vol. 2024, pp. 1-20
Open Access | Times Cited: 2
Samaneh Vaziri–Amjad, Reza Rahgosha, Amir Taherkhani
Evidence-based Complementary and Alternative Medicine (2024) Vol. 2024, pp. 1-20
Open Access | Times Cited: 2
Design, synthesis and pharmacological evaluation of novel thiazole derivatives as c-Met kinase inhibitors and anticancer agents
Piyush Gediya, Kartik Tulsian, Vivek K. Vyas, et al.
Journal of Molecular Structure (2024) Vol. 1317, pp. 139074-139074
Closed Access | Times Cited: 2
Piyush Gediya, Kartik Tulsian, Vivek K. Vyas, et al.
Journal of Molecular Structure (2024) Vol. 1317, pp. 139074-139074
Closed Access | Times Cited: 2
In silico screening, ADMET analysis and MD simulations of phytochemicals of Onosma bracteata Wall. as SARS CoV-2 inhibitors
Udaykumar G. Vegad, Normi D. Gajjar, Prinsa R. Nagar, et al.
3 Biotech (2023) Vol. 13, Iss. 7
Open Access | Times Cited: 7
Udaykumar G. Vegad, Normi D. Gajjar, Prinsa R. Nagar, et al.
3 Biotech (2023) Vol. 13, Iss. 7
Open Access | Times Cited: 7
Probing the molecular mechanisms of α-synuclein inhibitors unveils promising natural candidates through machine-learning QSAR, pharmacophore modeling, and molecular dynamics simulations
Yassir Boulaamane, Kailash Jangid, Mohammed Réda Britel, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2495-2511
Closed Access | Times Cited: 6
Yassir Boulaamane, Kailash Jangid, Mohammed Réda Britel, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2495-2511
Closed Access | Times Cited: 6
Association of dietary intake of polyphenols, lignans, and phytosterols with immune-stimulating microbiota and COVID-19 risk in a group of Polish men and women
Agnieszka Micek, Izabela Bolesławska, Paweł Jagielski, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 5
Agnieszka Micek, Izabela Bolesławska, Paweł Jagielski, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 5
In Silico Approach Triterpene Glycoside of H. atra Targeting Orotidine 5-Monophosphate Decarboxylase Protein (PfOMPDC) in P. falciparum Infection Mechanism
Prawesty Diah Utami, Herin Setianingsih, Dewi Ratih Tirto Sari
BioMed Research International (2024) Vol. 2024, pp. 1-14
Open Access | Times Cited: 1
Prawesty Diah Utami, Herin Setianingsih, Dewi Ratih Tirto Sari
BioMed Research International (2024) Vol. 2024, pp. 1-14
Open Access | Times Cited: 1
Insilico discovery of novel Phosphodiesterase 4 (PDE4) inhibitors for the treatment of psoriasis: Insights from computer aided drug design approaches
Abdullah R. Alanzi, Mohammed S. Alsalhi, Ramzi A. Mothana, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0305934-e0305934
Open Access | Times Cited: 1
Abdullah R. Alanzi, Mohammed S. Alsalhi, Ramzi A. Mothana, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0305934-e0305934
Open Access | Times Cited: 1
Molecular Docking Studies of Boron‐Containing Compounds as Dual Inhibitors of SARS‐Cov‐2 Spike Receptor Binding Domain/ACE2 Complex and Main Protease and ADMET Investigations
Selami Ercan, Meryem Pir
ChemistrySelect (2023) Vol. 8, Iss. 47
Closed Access | Times Cited: 2
Selami Ercan, Meryem Pir
ChemistrySelect (2023) Vol. 8, Iss. 47
Closed Access | Times Cited: 2
Design, Synthesis and Pharmacological Evaluation of Novel Thiazole-Based Peptide Like Molecules as C-Met Kinase Inhibitors and Anticancer Agents
Manjunath Ghate, Vivek K. Vyas, Kartik Tulsian, et al.
(2024)
Closed Access
Manjunath Ghate, Vivek K. Vyas, Kartik Tulsian, et al.
(2024)
Closed Access
Recent Advancements and Developments of Molecular Dynamics Simulations in the Discovery of Anti‐protozoal Agents
Tejas M. Dhameliya, Drashtiben D. Vekariya, Vaidehi N. Vaddoriya, et al.
ChemistrySelect (2024) Vol. 9, Iss. 1
Closed Access
Tejas M. Dhameliya, Drashtiben D. Vekariya, Vaidehi N. Vaddoriya, et al.
ChemistrySelect (2024) Vol. 9, Iss. 1
Closed Access
Exploring the conformational dynamics and key amino acids in the CD26-caveolin-1 interaction and potential therapeutic interventions
Xiaopeng Hu, Chunmei Jiang, Yanli Gu, et al.
Medicine (2024) Vol. 103, Iss. 22, pp. e38367-e38367
Open Access
Xiaopeng Hu, Chunmei Jiang, Yanli Gu, et al.
Medicine (2024) Vol. 103, Iss. 22, pp. e38367-e38367
Open Access
Elucidating the monoamine oxidase B inhibitory effect of kaurene diterpenoids from Xylopia aethiopica: An in silico approach
Funmilayo Gladys Famuyiwa, Rajesh B. Patil, Samson O. Famuyiwa, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0308021-e0308021
Open Access
Funmilayo Gladys Famuyiwa, Rajesh B. Patil, Samson O. Famuyiwa, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0308021-e0308021
Open Access
Discovery of Natural Compounds as SARS-CoV-2’s Main Protease Inhibitors by Docking-based Virtual Screening
Jing Wang, Yu Jiang, Yingnan Wu, et al.
Letters in Drug Design & Discovery (2023) Vol. 21, Iss. 10, pp. 1604-1610
Closed Access
Jing Wang, Yu Jiang, Yingnan Wu, et al.
Letters in Drug Design & Discovery (2023) Vol. 21, Iss. 10, pp. 1604-1610
Closed Access
